Pineridge Advisors’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Pineridge Advisors’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300	Closed	-$2.89K	–	856
2023 Q4	$2.89K	Buy	+300	New	+$3.21K	﹤0.01%	583

Pineridge Advisors's PBAXU Position: Q1 2024 in Review

Pineridge Advisors sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q1 2024, closing a stake of 300 shares — an estimated $2.89K sold.

Pineridge Advisors first reported a position in PBAXU in Q4 2023 and held it in 1 quarter. The position peaked at $2.89K in Q4 2023. 0 funds tracked by Wall St. Rank hold PBAXU as of Q1 2024.

Pineridge Advisors reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q1 2024 after selling out during the quarter.
Pineridge Advisors sold 300 Phoenix Biotech Acquisition Corp. Unit shares in Q1 2024, an estimated $2.89K.
Pineridge Advisors first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2023 and held it in 1 quarter.
Pineridge Advisors's Phoenix Biotech Acquisition Corp. Unit position peaked at $2.89K in Q4 2023.
0 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q1 2024.

Based on Pineridge Advisors's 13F filing for Q1 2024, filed 16 May 2024.